Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 86

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

The role of p53 in developmental syndromes

Bowen, Margot E, Attardi, Laura D·2019·Journal of Molecular Cell Biology
DOI 10.1093/jmcb/mjy087
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jmcb/mjy087

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 117

  1. Adam, 2007, A role for Xrcc2 in the early stages of mouse development, DNA Repair, 6, 224, 10.1016/j.dnarep.2006.10.024 · DOI
  2. Albers, 2012, Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome, Nat. Genet., 44, 435, 10.1038/ng.1083 · DOI · Paper page
  3. Alkuraya, 2011, Human mutations in NDE1 cause extreme microcephaly with lissencephaly, Am. J. Hum. Genet., 88, 536, 10.1016/j.ajhg.2011.04.003 · DOI · Paper page
  4. Alt, 2003, Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis, EMBO J., 22, 1442, 10.1093/emboj/cdg133 · DOI · Paper page
  5. Altmann, 2016, DNA ligase IV syndrome; a review, Orphanet J. Rare Dis., 11, 137, 10.1186/s13023-016-0520-1 · DOI
  6. Arbiv, 2018, Molecular analysis and genotype-phenotype correlation of Diamond–Blackfan anemia, Clin. Genet., 93, 320, 10.1111/cge.13158 · DOI
  7. Armstrong, 1995, High-frequency developmental abnormalities in p53-deficient mice, Curr. Biol., 5, 931, 10.1016/S0960-9822(95)00183-7 · DOI · Paper page
  8. Arora, 2012, Effect of maternal Tp53 gene G412C polymorphism on neural tube defects: a study from North India, Indian J. Hum. Genet., 18, 177, 10.4103/0971-6866.100757 · doi:10.4103/0971-6866.100757
  9. Aspesi, 2017, Lymphoblastoid cell lines from Diamond Blackfan anaemia patients exhibit a full ribosomal stress phenotype that is rescued by gene therapy, Sci. Rep., 7, 12010, 10.1038/s41598-017-12307-5 · DOI
  10. Baatout, 2002, Developmental abnormalities induced by X-irradiation in p53 deficient mice, In Vivo, 16, 215
  11. Barkić, 2009, The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival, Mol. Cell. Biol., 29, 2489, 10.1128/MCB.01588-08 · DOI
  12. Barlow, 2010, A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q− syndrome, Nat. Med., 16, 59, 10.1038/nm.2063 · DOI · Paper page
  13. Bazzi, 2014, Acentriolar mitosis activates a p53-dependent apoptosis pathway in the mouse embryo, Proc. Natl Acad. Sci. USA, 111, E1491, 10.1073/pnas.1400568111 · DOI · Paper page
  14. Bianchi, 2017, Citron kinase deficiency leads to chromosomal instability and TP53-sensitive microcephaly, Cell Rep., 18, 1674, 10.1016/j.celrep.2017.01.054 · DOI
  15. Bieging, 2014, Unravelling mechanisms of p53-mediated tumour suppression, Nat. Rev. Cancer, 14, 359, 10.1038/nrc3711 · DOI · Paper page
  16. Bojesen, 2008, The common germline Arg72Pro polymorphism of p53 and increased longevity in humans, Cell Cycle, 7, 158, 10.4161/cc.7.2.5249 · DOI
  17. Bonaventure, 2013, Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells, Pigment Cell Melanoma Res., 26, 316, 10.1111/pcmr.12080 · DOI · Paper page
  18. Boudjadi, 2018, The expression and function of PAX3 in development and disease, Gene, 666, 145, 10.1016/j.gene.2018.04.087 · DOI
  19. Bouwman, 2011, Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression, J. Pathol., 224, 10, 10.1002/path.2861 · DOI
  20. Bronner, 2016, Curr. Top. Dev. Biol., 115
  21. Bursac, 2014, Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis, Biochim. Biophys. Acta, 1842, 817, 10.1016/j.bbadis.2013.08.014 · DOI
  22. Caprio, 2014, p53 suppression partially rescues the mutant phenotype in mouse models of DiGeorge syndrome, Proc. Natl Acad. Sci. USA, 111, 13385, 10.1073/pnas.1401923111 · DOI
  23. Ceccaldi, 2012, Bone marrow failure in fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells, Cell Stem Cell, 11, 36, 10.1016/j.stem.2012.05.013 · DOI · Paper page
  24. Chang, 2017, CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation, Proc. Natl Acad. Sci. USA, 114, E8035, 10.1073/pnas.1702763114 · DOI
  25. Chavez-Reyes, 2003, Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets, Cancer Res., 63, 8664
  26. Chrzanowska, 2012, Nijmegen breakage syndrome (NBS), Orphanet J. Rare Dis., 7, 13, 10.1186/1750-1172-7-13 · DOI · Paper page
  27. Dauwerse, 2011, Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome, Nat. Genet., 43, 20, 10.1038/ng.724 · DOI · Paper page
  28. de Villartay, 2015, When natural mutants do not fit our expectations: the intriguing case of patients with XRCC4 mutations revealed by whole-exome sequencing, EMBO Mol. Med., 7, 862, 10.15252/emmm.201505307 · DOI
  29. Dixon, 2006, Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities, Proc. Natl Acad. Sci. USA, 103, 13403, 10.1073/pnas.0603730103 · DOI · Paper page
  30. Dokal, 2011, Dyskeratosis congenita, Hematology, 2011, 480, 10.1182/asheducation-2011.1.480 · DOI · Paper page
  31. Dumont, 2003, The codon 72 polymorphic variants of p53 have markedly different apoptotic potential, Nat. Genet., 33, 357, 10.1038/ng1093 · DOI · Paper page
  32. Dutt, 2011, Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells, Blood, 117, 2567, 10.1182/blood-2010-07-295238 · DOI · Paper page
  33. Else, 2009, Genetic p53 Deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis, Cancer Cell, 15, 465, 10.1016/j.ccr.2009.04.011 · DOI · Paper page
  34. Favaro, 2014, A noncoding expansion in EIF4A3 causes Richieri-Costa-Pereira Syndrome, a craniofacial disorder associated with limb defects, Am. J. Hum. Genet., 94, 120, 10.1016/j.ajhg.2013.11.020 · DOI
  35. Frank, 2000, DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway, Mol. Cell, 5, 993, 10.1016/S1097-2765(00)80264-6 · DOI · Paper page
  36. Frappart, 2005, An essential function for NBS1 in the prevention of ataxia and cerebellar defects, Nat. Med., 11, 538, 10.1038/nm1228 · DOI · Paper page
  37. Gao, 2000, Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development, Nature, 404, 897, 10.1038/35009138 · DOI · Paper page
  38. Gao, 2013, Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome, Curr. Allergy Asthma Rep., 13, 613, 10.1007/s11882-013-0384-6 · doi:10.1007/s11882-013-0384-6
  39. García-Cao, 2002, ‘Super p53’ mice exhibit enhanced DNA damage response, are tumor resistant and age normally, EMBO J., 21, 6225, 10.1093/emboj/cdf595 · DOI · Paper page
  40. Hamard, 2013, The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo, Genes Dev., 27, 1868, 10.1101/gad.224386.113 · DOI
  41. Hart, 2017, Neural tube defects in Waardenburg syndrome: a case report and review of the literature, Am. J. Med. Genet. A, 173, 2472, 10.1002/ajmg.a.38325 · doi:10.1002/ajmg.a.38325
  42. Hir, 2016, The exon junction complex as a node of post-transcriptional networks, Nat. Rev. Mol. Cell Biol., 17, 41, 10.1038/nrm.2015.7 · DOI · Paper page
  43. Houlihan, 2014, The scaffold protein Nde1 safeguards the brain genome during S phase of early neural progenitor differentiation, eLife, 3, e03297, 10.7554/eLife.03297 · DOI
  44. Insolera, 2014, Cortical neurogenesis in the absence of centrioles, Nat. Neurosci., 17, 1528, 10.1038/nn.3831 · DOI · Paper page
  45. Johnson, 2005, The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality, Nat. Genet., 37, 145, 10.1038/ng1498 · DOI
  46. Jones, 2008, Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function, Nat. Med., 14, 125, 10.1038/nm1725 · DOI · Paper page
  47. Kaiser, 2018, Deconstructing networks of p53-mediated tumor suppression in vivo, Cell Death Differ., 25, 93, 10.1038/cdd.2017.171 · DOI · Paper page
  48. Kaufman, 1997, Analysis of fused maxillary incisor dentition in p53-deficient exencephalic mice, J. Anat., 191, 57, 10.1046/j.1469-7580.1997.19110057.x · DOI
  49. Kitami, 2018, BRCA1 and BRCA2 tumor suppressors in neural crest cells are essential for craniofacial bone development, PLoS Genet., 14, e1007340, 10.1371/journal.pgen.1007340 · DOI
  50. Lau, 2016, Pathogenesis of POLR1C-dependent Type 3 Treacher Collins syndrome revealed by a zebrafish model, Biochim. Biophys. Acta, 1862, 1147, 10.1016/j.bbadis.2016.03.005 · DOI
  51. Lee, 2016, DNA damage to human genetic disorders with neurodevelopmental defects, J. Genet. Med., 13, 1, 10.5734/JGM.2016.13.1.1 · DOI
  52. Lei, 2017, Spliceosomal protein eftud2 mutation leads to p53-dependent apoptosis in zebrafish neural progenitors, Nucleic Acids Res., 45, 3422, 10.1093/nar/gkw1043 · DOI
  53. Leibowitz, 2018, Targeting p53-dependent stem cell loss for intestinal chemoprotection, Sci. Transl. Med., 10, eaam7610, 10.1126/scitranslmed.aam7610 · DOI
  54. Lessel, 2017, Dysfunction of the MDM2/p53 axis is linked to premature aging, J. Clin. Invest., 127, 3598, 10.1172/JCI92171 · DOI
  55. Li, 2016, Biallelic mutations in citron kinase link mitotic cytokinesis to human primary microcephaly, Am. J. Hum. Genet., 99, 501, 10.1016/j.ajhg.2016.07.004 · DOI
  56. Li, 2018, Cell-cycle-specific function of p53 in Fanconi anemia hematopoietic stem and progenitor cell proliferation, Stem Cell Rep., 10, 339, 10.1016/j.stemcr.2017.12.006 · DOI
  57. Lim, 1996, A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53, Mol. Cell. Biol., 16, 7133, 10.1128/MCB.16.12.7133 · DOI · Paper page
  58. Liu, 2003, Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis, Dev. Cell, 5, 903, 10.1016/S1534-5807(03)00339-3 · DOI
  59. Liu, 2010, Puma is required for p53-induced depletion of adult stem cells, Nat. Cell Biol., 12, 993, 10.1038/ncb2100 · DOI
  60. Liu, 2007, The p53-Mdm2 network in progenitor cell expansion during mouse postnatal development, J. Pathol., 213, 360, 10.1002/path.2238 · DOI
  61. Maier, 2004, Modulation of mammalian life span by the short isoform of p53, Genes Dev., 18, 306, 10.1101/gad.1162404 · DOI · Paper page
  62. Mamrak, 2017, Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia, Blood Rev., 31, 93, 10.1016/j.blre.2016.10.002 · DOI
  63. Mao, 2016, Haploinsufficiency for core exon junction complex components disrupts embryonic neurogenesis and causes p53-mediated microcephaly, PLoS Genet., 12, e1006282, 10.1371/journal.pgen.1006282 · DOI
  64. Marjanović, 2015, CEP63 deficiency promotes p53-dependent microcephaly and reveals a role for the centrosome in meiotic recombination, Nat. Commun., 6, 7676, 10.1038/ncomms8676 · DOI
  65. McDonald-McGinn, 2015, 22q11.2 deletion syndrome, Nat. Rev. Dis. Primer, 1, 15071, 10.1038/nrdp.2015.71 · DOI · Paper page
  66. McGowan, 2008, Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects, Nat. Genet., 40, 963, 10.1038/ng.188 · DOI · Paper page
  67. McMahon, 2016, The exon junction complex in neural development and neurodevelopmental disease, Int. J. Dev. Neurosci., 55, 117, 10.1016/j.ijdevneu.2016.03.006 · DOI
  68. Mendrysa, 2003, mdm2 is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation, Mol. Cell. Biol., 23, 462, 10.1128/MCB.23.2.462-473.2003 · DOI · Paper page
  69. Mlody, 2017, Nijmegen Breakage Syndrome fibroblasts and iPSCs: cellular models for uncovering disease-associated signaling pathways and establishing a screening platform for anti-oxidants, Sci. Rep., 7, 7516, 10.1038/s41598-017-07905-2 · DOI
  70. Morgan, 2008, Cardiac outflow tract septation failure in Pax3-deficient embryos is due to p53-dependent regulation of migrating cardiac neural crest, Mech. Dev., 125, 757, 10.1016/j.mod.2008.07.003 · DOI
  71. Moyer, 2017, Mdm proteins: critical regulators of embryogenesis and homoeostasis, J. Mol. Cell Biol., 9, 16, 10.1093/jmcb/mjx004 · DOI
  72. Nigg, 2018, Once and only once: mechanisms of centriole duplication and their deregulation in disease, Nat. Rev. Mol. Cell Biol., 19, 297, 10.1038/nrm.2017.127 · DOI · Paper page
  73. Noack Watt, 2016, The roles of RNA polymerase I and III subunits Polr1c and Polr1d in craniofacial development and in zebrafish models of Treacher Collins syndrome, PLoS Genet., 12, e1006187, 10.1371/journal.pgen.1006187 · DOI
  74. Pani, 2002, Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis, Genes Dev., 16, 676, 10.1101/gad.969302 · DOI · Paper page
  75. Pant, 2016, Distinct downstream targets manifest p53-dependent pathologies in mice, Oncogene, 35, 5713, 10.1038/onc.2016.111 · DOI
  76. Pellagatti, 2010, Induction of p53 and up-regulation of the p53 pathway in the human 5q− syndrome, Blood, 115, 2721, 10.1182/blood-2009-12-259705 · DOI
  77. Percival, 2015, Variations in dysfunction of sister chromatid cohesion in esco2 mutant zebrafish reflect the phenotypic diversity of Roberts syndrome, Dis. Model. Mech., 8, 941, 10.1242/dmm.019059 · DOI
  78. Pereboeva, 2016, Robust DNA damage response and elevated reactive oxygen species in TINF2-mutated dyskeratosis congenita cells, PLoS One, 11, e0148793, 10.1371/journal.pone.0148793 · DOI
  79. Pereboom, 2011, A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization, Blood, 118, 5458, 10.1182/blood-2011-04-351460 · DOI
  80. Perry, 2010, The regulation of the p53-mediated stress response by MDM2 and MDM4, Cold Spring Harb. Perspect. Biol., 2, a000968, 10.1101/cshperspect.a000968 · DOI
  81. Rana, 2013, A molecular and genetic outline of cardiac morphogenesis, Acta Physiol., 207, 588, 10.1111/apha.12061 · DOI
  82. Rinon, 2011, p53 coordinates cranial neural crest cell growth and epithelial-mesenchymal transition/delamination processes, Dev. Camb. Engl., 138, 1827
  83. Roake, 2017, Control of cellular aging, tissue function, and cancer by p53 downstream of telomeres, Cold Spring Harb. Perspect. Med., 7, a026088, 10.1101/cshperspect.a026088 · DOI
  84. Rosenfeld, 2012, Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes, Eur. J. Hum. Genet., 20, 754, 10.1038/ejhg.2012.6 · DOI
  85. Sah, 1995, A subset of p53-deficient embryos exhibit exencephaly, Nat. Genet., 10, 175, 10.1038/ng0695-175 · DOI · Paper page
  86. Saifudeen, 2009, p53 Regulates metanephric development, J. Am. Soc. Nephrol., 20, 2328, 10.1681/ASN.2008121224 · doi:10.1681/asn.2008121224
  87. Sakai, 2016, Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation, Nat. Commun., 7, 10328, 10.1038/ncomms10328 · DOI
  88. Sakai, 2016, Face off against ROS: Tcof1/Treacle safeguards neuroepithelial cells and progenitor neural crest cells from oxidative stress during craniofacial development, Dev. Growth Differ., 58, 577, 10.1111/dgd.12305 · DOI
  89. Simeonova, 2013, Mutant mice lacking the p53 C-terminal domain model telomere syndromes, Cell Rep., 3, 2046, 10.1016/j.celrep.2013.05.028 · DOI
  90. Slomnicki, 2017, Ribosomal stress and Tp53-mediated neuronal apoptosis in response to capsid protein of the Zika virus, Sci. Rep., 7, 16652, 10.1038/s41598-017-16952-8 · DOI
  91. Su, 2017, ROCK1/p53/NOXA signaling mediates cardiomyocyte apoptosis in response to high glucose in vitro and vivo, Biochim. Biophys. Acta, 1863, 936, 10.1016/j.bbadis.2017.01.021 · DOI · Paper page
  92. Szybińska, 2017, P53 dysfunction in neurodegenerative diseases—the cause or effect of pathological changes?, Aging Dis., 8, 506, 10.14336/AD.2016.1120 · DOI
  93. Tateossian, 2015, Interactions between the otitis media gene, Fbxo11, and p53 in the mouse embryonic lung, Dis. Model Mech., 8, 1531, 10.1242/dmm.022426 · DOI
  94. Terzian, 2011, Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models, J. Pathol., 224, 540, 10.1002/path.2891 · DOI
  95. Terzian, 2007, Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development, Mol. Cell. Biol., 27, 5479, 10.1128/MCB.00555-06 · DOI · Paper page
  96. Thurow, 2011, TP53 gene polymorphism: importance to cancer, ethnicity and birth weight in a Brazilian cohort, J. Biosci., 36, 823, 10.1007/s12038-011-9147-5 · DOI
  97. Toki, 2018, De novo mutations activating germline TP53 in an inherited bone-marrow-failure syndrome, Am. J. Hum. Genet., 103, 440, 10.1016/j.ajhg.2018.07.020 · DOI · Paper page
  98. Tonks, 2012, Brca1 is involved in establishing murine pigmentation in a p53 and developmentally specific manner: letter to the editor, Pigment Cell Melanoma Res., 25, 530, 10.1111/j.1755-148X.2012.01009.x · DOI
  99. Valdez, 2017, Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition, Br. J. Haematol., 176, 539, 10.1111/bjh.14461 · DOI
  100. Van Nostrand, 2014, Guilty as CHARGED: p53’s expanding role in disease, Cell Cycle, 13, 3798, 10.4161/15384101.2014.987627 · DOI
  101. Van Nostrand, 2014, Inappropriate p53 activation during development induces features of CHARGE syndrome, Nature, 514, 228, 10.1038/nature13585 · DOI · Paper page
  102. Vincent, 2016, Treacher Collins syndrome: a clinical and molecular study based on a large series of patients, Genet. Med., 18, 49, 10.1038/gim.2015.29 · DOI · Paper page
  103. Volta, 2013, RACK1 depletion in a mouse model causes lethality, pigmentation deficits and reduction in protein synthesis efficiency, Cell. Mol. Life Sci., 70, 1439, 10.1007/s00018-012-1215-y · DOI
  104. Wang, 2016, Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode, Nature, 538, 118, 10.1038/nature19759 · DOI · Paper page
  105. Wang, 2011, Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity, Genes Dev., 25, 1426, 10.1101/gad.2024411 · DOI · Paper page
  106. Wang, 2011, Pax3 stimulates p53 ubiquitination and degradation independent of transcription, PLoS One, 6, e29379, 10.1371/journal.pone.0029379 · DOI
  107. Watkins-Chow, 2013, Mutation of the Diamond-Blackfan anemia gene Rps7 in mouse results in morphological and neuroanatomical phenotypes, PLoS Genet., 9, e1003094, 10.1371/journal.pgen.1003094 · DOI
  108. Williams, 2015, Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in mice, Development, 142, 3921, 10.1242/dev.124271 · DOI
  109. Wu, 2018, Relevance of the p53–MDM2 axis to aging, Cell Death Differ., 25, 169, 10.1038/cdd.2017.187 · DOI · Paper page
  110. Xu, 2001, Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis, Nat. Genet., 28, 266, 10.1038/90108 · DOI · Paper page
  111. Yelick, 2015, Ribosomopathies: global process, tissue specific defects, Rare Dis., 3, e1025185, 10.1080/21675511.2015.1025185 · DOI
  112. Yuan, 2017, Up-regulation of Siah1 by ethanol triggers apoptosis in neural crest cells through p38 MAPK-mediated activation of p53 signaling pathway, Arch. Toxicol., 91, 775, 10.1007/s00204-016-1746-3 · DOI
  113. Zaqout, 2017, Autosomal recessive primary microcephaly (MCPH):, Neuropediatrics, 48, 135, 10.1055/s-0037-1601448 · doi:10.1055/s-0037-1601448
  114. Zentner, 2010, Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome, Am. J. Med. Genet. A, 152A, 674, 10.1002/ajmg.a.33323 · DOI · Paper page
  115. Zhang, 2012, Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development, J. Pathol., 228, 416, 10.1002/path.4077 · DOI
  116. Zhang, 2012, Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing, PLoS One, 7, e30188, 10.1371/journal.pone.0030188 · DOI
  117. Zohn, 2012, Mouse as a model for multifactorial inheritance of neural tube defects, Birth Defects Res. C Embryo Today, 96, 193, 10.1002/bdrc.21011 · DOI

Cited by

See all 86

Metadata

Authors
Bowen, M. E., & Attardi, L. D.
Affiliations
Division of Radiation and Cancer Biology in the Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
ORCID
Bowen, Margot E
Venue
Journal of Molecular Cell Biology
Publisher
Oxford University Press (OUP)
Published
2019-01-08
Volume
11
Issue
3
Pages
200-211
ISSN
1759-4685
DOI
10.1093/jmcb/mjy087
Cited by
86
References
10
Language
en
Licence
creativecommons.org/licenses/by-nc/4.0/ (vor)
Funders
  • March of Dimes Foundation (6-FY15-189, CA197591)
  • Jane Coffin Childs Fund Postdoctoral Fellowship

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of p53 in developmental syndromes. https://app.cochat.ai/papers/10.1093/jmcb/mjy087
The paper
Bowen, M. E., & Attardi, L. D. (2019). The role of p53 in developmental syndromes. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjy087

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.